Exhibitor

CROss Alliance® is a family owned Swiss CRO specialised in EARLY clinical development since 1997. With more than 500 phase I-II trials performed with drugs and medical devices at CROSS phase I unit in CH or in selected EU sites, we are experts in Pharmacokinetics, Bioequivalence, First in man, Tolerability studies including Cardiac Safety and Efficacy Models in healthy volunteers. Major expertise for phase II trials in: GI, Orthopaedics, Dermatology and Ophthalmology.